Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Guardant Health, Inc. - Common Stock
(NQ:
GH
)
42.60
-0.54 (-1.25%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Guardant Health, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
4 Healthcare Stocks With Massive Gains—and More to Come
March 29, 2025
Healthcare is the top industry of 2025 so far. These healthcare companies have seen 30% increases in share prices since the beginning of the year.
Via
MarketBeat
Topics
Artificial Intelligence
Economy
World Trade
Exposures
Artificial Intelligence
Economy
Tariff
The Future of Healthcare: 10 Predictions For The Next Decade
March 27, 2025
The healthcare industry stands on the brink of a transformative decade, driven by rapid advancements in technology, shifting demographics, and evolving patient expectations. Over the next ten years, we...
Via
MarketMinute
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
COVID-19
A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack
March 27, 2025
Looking back on testing & diagnostics services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Labcorp (NYSE:LH) and its peers.
Via
StockStory
Earnings Scheduled For February 20, 2025
February 20, 2025
Via
Benzinga
Q4 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Impresses
March 26, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q4, starting...
Via
StockStory
1 Healthcare Stock on Our Watchlist and 2 to Turn Down
March 20, 2025
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and...
Via
StockStory
Topics
Stocks
Exposures
COVID-19
US Equities
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)
March 14, 2025
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Quest (NYSE:DGX) and the best and worst...
Via
StockStory
1 Stock Under $50 with Solid Fundamentals and 2 to Turn Down
March 13, 2025
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to...
Via
StockStory
Medicare To Reimburse Guardant Health's Shield Colorectal Cancer Test, Analyst Expects $10M In Revenue
March 11, 2025
CMS approves ADLT status for Guardant Health's Shield test, setting Medicare reimbursement at $1,495. The analyst sees a potential revenue boost from the decision.
Via
Benzinga
Korn Ferry Posts Better-Than-Expected Earnings, Joins Bioventus, Endeavour Silver, Vail Resorts And Other Big Stocks Moving Higher On Tuesday
March 11, 2025
Via
Benzinga
Healthcare Stocks Doing Well But SMID Biotech Looking A Little Frazzled
March 10, 2025
Small caps took another step down this past week as geopolitical events dampened sentiment.
Via
Talk Markets
Topics
ETFs
Stocks / Equities
Guardant Health’s (NASDAQ:GH) Q4: Beats On Revenue
March 03, 2025
Diagnostics company Guardant Health (NASDAQ:GH) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 30.2% year on year to $201.8 million. Its GAAP loss of $0.90 per share was 12.4%...
Via
StockStory
What's Going On With Cancer Diagnostic Firm Guardant Health On Friday?
February 21, 2025
Guardant Health beat Q4 estimates with a smaller EPS loss and strong revenue growth. Analysts raised price targets, citing momentum and solid financials.
Via
Benzinga
Guardant Health Tops Q4 Revenue Forecast
February 20, 2025
The oncology testing specialist reported strong top-line growth, but also rising costs and ongoing net losses.
Via
The Motley Fool
Okla And Rigetti Computing Are Among Top 8 Mid Cap Gainers Last Week (Jan 20-Jan 24): Are The Others In Your Portfolio?
January 26, 2025
Top performers in last week's mid-cap stocks: Oklo Inc., Tempus AI, Himax Tech, Super Group, NuScale Power, WNS Holdings, Guardant Health, Rigetti Computing.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Guardant Health Gains Medicare Coverage For Colorectal Cancer Monitoring Test
January 21, 2025
Guardant Reveal test receives expanded Medicare coverage for colorectal cancer recurrence monitoring, enhancing revenue potential and clinical adoption.
Via
Benzinga
Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone
January 21, 2025
The company is working to expand the uses and reimbursement for its blood-based tests for cancer.
Via
Investor's Business Daily
Charles Schwab Posts Upbeat Earnings, Joins Redwire, Evolus, Replimune Group And Other Big Stocks Moving Higher On Tuesday
January 21, 2025
Via
Benzinga
Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio?
January 12, 2025
These mid-cap stocks had impressive gains last week, including Inari Medical, Unifirst Corporation, and Walgreens. Are they in your portfolio?
Via
Benzinga
Guardant Health Stock Sees RS Rating Jump To 83
November 20, 2024
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83.
Via
Investor's Business Daily
Deciphering Disruption: Inside Cathie Wood's Latest Plays
November 16, 2024
Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies.
Via
MarketBeat
Topics
Artificial Intelligence
ETFs
Exposures
Artificial Intelligence
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
November 12, 2024
The rock star money manager is starting to roll with the rallying market.
Via
The Motley Fool
Smaller Cap Biotechs Are In Season: How Are We Doing?
November 07, 2024
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range.
Via
Talk Markets
Why Guardant Health Stock Blasted 13% Higher on Thursday
November 07, 2024
Via
The Motley Fool
HubSpot Posts Better-Than-Expected Results, Joins Under Armour, Lyft, Wolverine World Wide, Zillow And Other Big Stocks Moving Higher On Thursday
November 07, 2024
Via
Benzinga
Guardant Health Rockets 25% On An 'Impressive' Beat Following Exact Sciences' Flop
November 07, 2024
The company also hiked its outlook for the year and guided to 20% growth in clinical volumes next year.
Via
Investor's Business Daily
Why Guardant Health Stock Was the Picture of Health Today
October 30, 2024
There's nothing like free publicity to help goose the sales of a relatively new product.
Via
The Motley Fool
FDA Clears Exact Sciences' Next-Generation Colorectal Cancer Diagnostic Test
October 04, 2024
Exact Sciences' Cologuard Plus test, now FDA-approved, offers a non-invasive screening option for adults 45+ at average risk for colorectal cancer. The test outperformed fecal immunochemical tests in...
Via
Benzinga
Exposures
Product Safety
Sky Harbour Group, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
September 17, 2024
Via
Benzinga
iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
September 16, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.